---
figid: PMC7913382__jcm-10-00566-g001
figtitle: Illustration of the HER2 signalling pathway
organisms:
- NA
pmcid: PMC7913382
filename: jcm-10-00566-g001.jpg
figlink: pmc/articles/PMC7913382/figure/jcm-10-00566-f001/
number: F1
caption: Illustration of the HER2 signalling pathway. HER2 inhibitor (trastuzumab);
  HER2/EGFR inhibitors (lapatinib and afatinib); HER2/HER3 inhibitor (zenocutuzumab).
papertitle: The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic
  Cancer Therapies.
reftext: Andres Garcia-Sampedro, et al. J Clin Med. 2021 Feb;10(4):566.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9680341
figid_alias: PMC7913382__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Danio rerio
redirect_from: /figures/PMC7913382__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7913382__jcm-10-00566-g001.html
  '@type': Dataset
  description: Illustration of the HER2 signalling pathway. HER2 inhibitor (trastuzumab);
    HER2/EGFR inhibitors (lapatinib and afatinib); HER2/HER3 inhibitor (zenocutuzumab).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - CycE
  - cyc
  - her2
  - her3
  - her4.1
  - egfra
  - rab1ab
  - Afatinib
  - Lapatinib
---
